Krebs Stephanie 4
4 · Sensei Biotherapeutics, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Krebs Stephanie
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-14+120,000→ 120,000 totalExercise: $0.48Exp: 2035-02-13→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 14, 2026, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.